Kevin DeMent

475 total citations
10 papers, 176 citations indexed

About

Kevin DeMent is a scholar working on Molecular Biology, Biological Psychiatry and Biochemistry. According to data from OpenAlex, Kevin DeMent has authored 10 papers receiving a total of 176 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Biological Psychiatry and 3 papers in Biochemistry. Recurrent topics in Kevin DeMent's work include Tryptophan and brain disorders (3 papers), Amino Acid Enzymes and Metabolism (2 papers) and Receptor Mechanisms and Signaling (2 papers). Kevin DeMent is often cited by papers focused on Tryptophan and brain disorders (3 papers), Amino Acid Enzymes and Metabolism (2 papers) and Receptor Mechanisms and Signaling (2 papers). Kevin DeMent collaborates with scholars based in France, United States and Switzerland. Kevin DeMent's co-authors include Patrick Brassil, David L. Bourdet, Jayaprakasam Bolleddula, James P. Driscoll, Philip Worboys, Edna F. Choo, Georgia Hatzivassiliou, Jodie Pang, Paula Katavolos and Dimitry M. Danilenko and has published in prestigious journals such as Circulation, Analytical Biochemistry and Toxicology and Applied Pharmacology.

In The Last Decade

Kevin DeMent

10 papers receiving 170 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin DeMent France 6 95 38 34 31 29 10 176
Leslie Nguyen United States 9 115 1.2× 19 0.5× 25 0.7× 15 0.5× 57 2.0× 11 267
Lisa Elkin United States 8 130 1.4× 17 0.4× 32 0.9× 54 1.7× 158 5.4× 13 325
Michael E. Prime United Kingdom 12 97 1.0× 28 0.7× 156 4.6× 7 0.2× 25 0.9× 12 342
Leeanne Zalameda United States 7 118 1.2× 77 2.0× 72 2.1× 4 0.1× 19 0.7× 9 220
Erica C. VanderPorten United States 9 178 1.9× 27 0.7× 30 0.9× 2 0.1× 67 2.3× 9 282
Alex G. Baldwin United Kingdom 8 205 2.2× 25 0.7× 69 2.0× 15 0.5× 36 1.2× 10 314
Haydn T. Jones United Kingdom 8 49 0.5× 30 0.8× 51 1.5× 19 0.6× 12 0.4× 12 177
Patrick Flannery United States 9 88 0.9× 5 0.1× 29 0.9× 42 1.4× 42 1.4× 20 229
Clare I. Hobbs United Kingdom 5 103 1.1× 29 0.8× 19 0.6× 1 0.0× 19 0.7× 5 147
Anna Gryboś Poland 12 149 1.6× 4 0.1× 117 3.4× 15 0.5× 32 1.1× 27 340

Countries citing papers authored by Kevin DeMent

Since Specialization
Citations

This map shows the geographic impact of Kevin DeMent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin DeMent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin DeMent more than expected).

Fields of papers citing papers by Kevin DeMent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin DeMent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin DeMent. The network helps show where Kevin DeMent may publish in the future.

Co-authorship network of co-authors of Kevin DeMent

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin DeMent. A scholar is included among the top collaborators of Kevin DeMent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin DeMent. Kevin DeMent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Mařı́k, Jan, Gauri Deshmukh, Donglu Zhang, et al.. (2023). GTP1 metabolic stability assessment: A study of the tau PET tracer [18F]GTP1. Nuclear Medicine and Biology. 124-125. 108386–108386. 1 indexed citations
2.
Chen, Buyun, Yang Gao, Edna F. Choo, et al.. (2018). Practical strategies when using a stable isotope labeled microtracer for absolute bioavailability assessment: A case study of a high oral dose clinical candidate GDC-0810. Journal of Pharmaceutical and Biomedical Analysis. 154. 116–122. 2 indexed citations
3.
Wang, Jing, Ryan Takahashi, Kevin DeMent, et al.. (2018). Development of a mass spectrometry-based tryptophan 2, 3-dioxygenase assay using liver cytosol from multiple species. Analytical Biochemistry. 556. 85–90. 3 indexed citations
4.
Pei, Zhonghua, Rohan Mendonca, Lewis Gazzard, et al.. (2018). Aminoisoxazoles as Potent Inhibitors of Tryptophan 2,3-Dioxygenase 2 (TDO2). ACS Medicinal Chemistry Letters. 9(5). 417–421. 34 indexed citations
5.
Tang, Tang, Herman Gill, Annie Ogasawara, et al.. (2017). Preparation and evaluation of L- and D-5-[ 18 F]fluorotryptophan as PET imaging probes for indoleamine and tryptophan 2,3-dioxygenases. Nuclear Medicine and Biology. 51. 10–17. 19 indexed citations
6.
Lee, Dong U., Paula Katavolos, Gopinath S. Palanisamy, et al.. (2016). Nonselective inhibition of the epigenetic transcriptional regulator BET induces marked lymphoid and hematopoietic toxicity in mice. Toxicology and Applied Pharmacology. 300. 47–54. 36 indexed citations
7.
Choo, Edna F., Sarah Woolsey, Kevin DeMent, et al.. (2015). Use of Transgenic Mouse Models to Understand the Oral Disposition and Drug-Drug Interaction Potential of Cobimetinib, a MEK Inhibitor. Drug Metabolism and Disposition. 43(6). 864–869. 15 indexed citations
8.
Bourdet, David L., Craig Hill, Kevin DeMent, et al.. (2015). Abstract 19056: Discovery of Potent and Selective Neprilysin Inhibitors Exhibiting Sustained Pharmacodynamic Activity and Non-renal Elimination in Rats. Circulation. 132(suppl_3). 1 indexed citations
9.
Bolleddula, Jayaprakasam, Kevin DeMent, James P. Driscoll, et al.. (2014). Biotransformation and bioactivation reactions of alicyclic amines in drug molecules. Drug Metabolism Reviews. 46(3). 379–419. 60 indexed citations
10.
Hegde, Laxminarayan G., Craig Hill, Kevin DeMent, et al.. (2011). Comparative efficacy of AHU-377, a potent neprilysin inhibitor, in two rat models of volume-dependent hypertension. BMC Pharmacology. 11(S1). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026